Yahoo
NasdaqCM - Nasdaq Real Time Price USD

NewGenIvf Group Limited (NIVF)

1.0350 -0.1050 (-9.21%)
As of 12:41:11 PM EDT. Market Open.
Chart Range Bar
Loading chart for NIVF
  • Previous Close 1.1400
  • Open 1.0400
  • Bid 1.1400 x 200
  • Ask 0.1476 x 1000
  • Day's Range 1.0000 - 1.1000
  • 52 Week Range 1.0000 - 20,908.8008
  • Volume 104,322
  • Avg. Volume 1,351,084
  • Market Cap (intraday) 10.241M
  • Beta (5Y Monthly) 0.06
  • PE Ratio (TTM) --
  • EPS (TTM) -34,064.7109
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 4,066.56

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

www.nivf.global

87

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NIVF
99.96%
S&P 500 (^GSPC)
11.06%

1-Year Return

NIVF
99.99%
S&P 500 (^GSPC)
11.44%

3-Year Return

NIVF
100.00%
S&P 500 (^GSPC)
82.46%

5-Year Return

NIVF
100.00%
S&P 500 (^GSPC)
65.09%

Analyst Insights

View More

Analyst Price Targets

4,066.56
4,066.56 Average
1.0350 Current
4,066.56 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    24.16%

  • Return on Assets (ttm)

    -26.91%

  • Return on Equity (ttm)

    5.51%

  • Revenue (ttm)

    4.63M

  • Net Income Avi to Common (ttm)

    1.12M

  • Diluted EPS (ttm)

    -34,064.7109

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.51M

  • Total Debt/Equity (mrq)

    6.41%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: